Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Omkar Speciality Chemicals Ltd
| Unaudited Financial Results – Q2 & H1 FY26
Summary : Omkar Speciality Chemicals is recovering from CIRP with an approved resolution plan, new leadership, and fund infusion, despite ongoing losses.
Quarterly Report Analysis & Insights
Financial Disclosures
- Total Expenses: Q1: 41.84 Lakhs, Q2: 59.50 Lakhs, Q3: 33.66 Lakhs
- Depreciation and amortisation: Q1: 22.31 Lakhs, Q2: 22.52 Lakhs, Q3: 22.52 Lakhs
- Revenue from operations: Nil for Q1, Q2, Q3 FY2025-26
- Other income: Q1: 0.86 Lakhs, Q2: 7.70 Lakhs, Q3: 0.82 Lakhs
- Net cash from operating activities (H1 FY2025-26): -138.66 Lakhs
- Net cash used in investing activities (H1 FY2025-26): -34.59 Lakhs
- Increase in other financial liabilities (H1 FY2025-26): 500.00 Lakhs
- Cash and cash equivalents at period end (30.09.2025): 39.30 Lakhs
- Total Assets (30.09.2025): 4,622.79 Lakhs
- Other Equity (30.09.2025): -119.22 Lakhs (vs -37,708.26 Lakhs on 31.03.2025)
- Current Borrowings (30.09.2025): 1,678.55 Lakhs (vs 38,235.31 Lakhs on 31.03.2025)
- Standalone financial results presented
Corporate Overview
- Registered office in Badlapur, Thane, Maharashtra, India
- Admitted into Corporate Insolvency Resolution Process (CIRP)
- Incurred losses and negative net worth
- No revenue from operations in recent quarters
- Dependent on successful implementation of Resolution Plan
- Dependent on funds infused by Resolution Applicant
- Speciality Chemicals manufacturing
- Company operates in a single segment
- Factual and procedural reporting
- Cautiously optimistic about revival post-CIRP
- Single operating segment
- Resolution Plan includes 351 lakhs for Capex and working capital
Risk Factors
- Company remains under Corporate Insolvency Resolution Process.
- Continued financial losses and negative net worth.
- Material uncertainty regarding going concern status.
- No operational revenue generated recently.
Key Drivers
- NCLT approved resolution plan.
- Resolution Applicant infused significant funds.
- New CEO and Independent Director appointed.
- Board committees reconstituted for governance.
Auditor’s Report
- Qualified Conclusion
- Company was under CIRP during the review period
- No comparative quarterly figures available for FY2024-25
- Incurred losses and negative net worth, raising going concern uncertainty
- Approval of Resolution Plan by NCLT on July 31, 2025, post-reporting period
Board Commentary
- Audit Committee constituted with independent directors
- Stakeholder's Relationship Committee constituted
- Mr. Ruhini Kumar Chakraborty appointed Independent Director
- Mr. Dipak Kumar Shaw appointed Chief Executive Officer (CEO)
- Statutory Auditors (R. R. Tibrewala & Co.) appointed
- Secretarial Auditor (M/s. Aabid & Co) appointed
- Incurred losses and negative net worth
- Material uncertainty related to going concern
- Admitted into CIRP via NCLT order on December 5, 2022
- Resolution Plan approved by NCLT on July 31, 2025
- Resolution Plan allocates 351 lakhs for Capex and working capital
- Resolution Applicant infused 1508.16 lakhs up to December 2025
Corporate Governance
- Compliance with Companies Act 2013 and SEBI Listing Regulations
- Audit Committee includes independent directors
- Stakeholder's Relationship Committee includes independent director
- New Independent Director appointed
- Audit Committee constituted
- Stakeholder's Relationship Committee constituted
- Monitoring Committee currently oversees operations
- Company was under Corporate Insolvency Resolution Process (CIRP)
Management Discussion & Analysis
Future Strategy
- Implementation of approved Resolution Plan
- Expected revival of operations
- Strengthening governance through committee constitution
- Appointing key managerial personnel
Operational Focus Areas
- Facilitate smooth day-to-day business operations
- Ensure compliance with SEBI Listing Regulations
Performance Drivers
- Approval and implementation of Resolution Plan
- Infusion of funds by Resolution Applicant
- Reconstitution of Board and committees
Risk Control Measures
- Financial results prepared on going concern basis due to approved Resolution Plan
- Resolution Applicant infused funds to support operations
Critical Risks
- Company under Corporate Insolvency Resolution Process (CIRP)
- Continued losses and negative net worth
- Material uncertainty related to going concern
- No revenue from operations in reported quarters